John Adams

John Adams is an accomplished scientific leader with extensive experience in the biopharmaceutical industry. Currently serving as Chief Scientific Officer at Inhibikase Therapeutics, Inc. and previously holding the same title at CorHepta Pharmaceuticals, John has demonstrated expertise in advancing scientific research and development. Prior to these roles, John held the position of Senior Vice President, Discovery Biology at Iambic Therapeutics and Senior Vice President, Translational Science at Reneo Pharmaceuticals, showcasing a strong background in both discovery and translational research.